OmniAb (OABI) Revenue (2022 - 2026)
OmniAb (OABI) reported Revenue of $14.4 million for Q1 2026, up 247.3% year-over-year from $4.2 million in Q1 2025, and up 72.24% on a QoQ basis from $8.4 million in Q4 2025.
OmniAb (OABI) has 5 years of Revenue data on file, last reported at $14.4 million in Q1 2026.
- Quarterly Revenue rose 247.3% year-over-year to $14.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $28.9 million (up 8.21% YoY) and the FY2025 annual result came in at $18.7 million, down 29.27% from the prior year.
- Revenue advanced to $14.4 million in Q1 2026 per OABI's latest filing, from $8.4 million in the prior quarter.
- Across five years, Revenue topped out at $35.3 million in Q4 2022 and bottomed at $2.2 million in Q3 2025.
- The 5-year median for Revenue is $6.9 million (2023), against an average of $9.0 million.
- The widest annual swing landed in 2023, when Revenue sank 86.36%; it then soared 247.3% in 2026.
- Tracing OABI's Revenue over 5 years: stood at $35.3 million in 2022, then slumped by 86.36% to $4.8 million in 2023, then soared by 124.06% to $10.8 million in 2024, then fell by 22.47% to $8.4 million in 2025, then jumped by 72.24% to $14.4 million in 2026.
- Per Business Quant, the three latest OABI Revenue figures stand at $14.4 million (Q1 2026), $8.4 million (Q4 2025), and $2.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 306.30 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 2.99 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.61 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.17 Bn |
| 10 | OmniAb | 334.72 Mn | 291.75 Mn | 14.41 Mn | 14.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.43 Mn |
| Dec 31, 2025 | 8.38 Mn |
| Sep 30, 2025 | 2.24 Mn |
| Jun 30, 2025 | 3.90 Mn |
| Mar 31, 2025 | 4.15 Mn |
| Dec 31, 2024 | 10.80 Mn |
| Sep 30, 2024 | 4.17 Mn |
| Jun 30, 2024 | 7.61 Mn |
| Mar 31, 2024 | 3.80 Mn |
| Dec 31, 2023 | 4.82 Mn |
| Sep 30, 2023 | 5.48 Mn |
| Jun 30, 2023 | 6.95 Mn |
| Mar 31, 2023 | 16.92 Mn |
| Dec 31, 2022 | 35.35 Mn |
| Sep 30, 2022 | 6.91 Mn |
| Jun 30, 2022 | 7.20 Mn |
| Mar 31, 2022 | 9.60 Mn |